EDI200
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EDI200, covering 2013-11-27 to 2016-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) [Phase 2]